[1] |
LU Tingting, SHI Lijun, LIU Yingzhao, LIANG Huiting, WANG Qi.
Down⁃regulation of α2⁃macroglobulin expression activates TGF⁃β/SMADs signaling pathway to induce cisplatin resistance in ovarian cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 707-714.
|
[2] |
CHEN Xiaoqi, ZHAO Bingbing, LI Zhuang, FENG Yanying, YANG Zhijun.
The role and mechanism of piR-hsa-130912 in promoting proliferation,invasion and migration ofepithelial ovarian cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 263-271.
|
[3] |
CHEN Chaomei, XI Min, SHI Xiu, WANG Fang, ZHOU Jinhua.
Effect of silencing G6PD on cisplatin sensitivity of ovarian cancer cells and its mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(3): 274-280.
|
[4] |
QIU Liyu, LI Ni, WU Guili.
Quality of life in advanced ovarian cancer patients undergoing hyperthermic intraperitoneal chemotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(5): 430-433.
|
[5] |
Tang Yuqi,Yu Hongjing,Shi Lijun,ZouYupeng,Feng Yan,Wang Qi.
Analysis of poor prognosis leaded by CCL18 mediated chemokine network in tumor microenvironment in ovarian cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 345-351.
|
[6] |
Lu Meiyan,Huang Zaiming,Yang Zhijun.
Prediction and identification of HLA-A2-restricted CTL epitopes from ovarian cancer-associated antigen TM4SF1
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(3): 198-204.
|
[7] |
Li Haimei, Yu Jinxia, Yang Haijun.
Clinical pathological analysis of 10 cases of ovarian sclerosingstromal tumor
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(2): 132-136.
|
[8] |
He Ying,Wei Minglang,Wang Daiyou.
The clinical comparative observation of preoperative induction chemotherapy with TOF or TPF regimen for advanced oral squamous cell carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(3): 161-164.
|
[9] |
Bai Feng,Fang Xianying,Song Bo,Zhang Yu.
Comparison of safety and efficacy of irinotecan or etoposide combined with cisplatin as first-line treatment for extensive stage small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(2): 122-125.
|
[10] |
CAI Zu′ai,ZHANG Wei.
Meta-analysis of the association between ERCC1 gene 19007C / T polymorphism and response of patients with epithelial ovarian cancer to platinum-based combination chemotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2015, 7(4): 276-281.
|
[11] |
LI Mengdi,SHI Lijun,LIU Hongmei,YANG Zhijun,PAN Zhongmian,LI Li,WANG Qi.
Association between A2M-induced Fas apoptotic signaling and ovarian tumor sensitivity to platinum-based chemotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2015, 7(2): 67-73.
|
[12] |
YANG Yu-fang,LIU Hua-gang,XI Jia-xi,LIU Xin-wen.
Effect of Panax Notoginsenosides on renal proteins differentially expressed in rats experi-encing cisplatin-induced nephrotoxicity
[J]. Chinese Journal of Oncology Prevention and Treatment, 2014, 6(4): 353-358.
|
[13] |
JIANG Guan-ming,YUAN Ling-qin,JIA Yun,LIN Shun-huan,CAI Yan-min,LIU Chun,WU Yi-fen,WANG Zai-guo,HUANG Shu-lin.
Efficacy and safety of combining infusion of antigen-activated,TCR gene-transfected memory T cells combined with chemotherapy for treating advanced non-small cell lung cancer resistant to EGFR-TKIs
[J]. Chinese Journal of Oncology Prevention and Treatment, 2014, 6(2): 167-171.
|
[14] |
CAI Zu-ai,WANG Qi,ZHANG Wei,LI Li,YIN Fu-qiang.
Using gene-set enrichment pathway analysis to identify signaling pathways and functional single nucleotide polymorphisms related to multi-drug resistance in epithelial ovarian cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2014, 6(2): 127-132.
|
[15] |
LIU Hui-min,FENG Yan-ying,GAO Cai-yun,YANG Zhi-jun.
Expression and clinical significance of TM4SF1 protein in epithelial ovarian cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2014, 6(1): 20-24.
|